Literature DB >> 33618755

"I have SMA, SMA doesn't have me": a qualitative snapshot into the challenges, successes, and quality of life of adolescents and young adults with SMA.

Allison Mazzella1, Mary Curry2, Lisa Belter2, Rosángel Cruz2, Jill Jarecki2.   

Abstract

BACKGROUND: With the approval of three treatments for spinal muscular atrophy (SMA) and several promising therapies on the horizon, the SMA adolescent and young adult populations are expected to evolve in the coming years. It is imperative to understand this cohort as it exists today to provide optimal care and resources, as well as to assess possible treatment effects over time. In 2018, Cure SMA launched two initiatives geared towards understanding adolescents and young adults with SMA, ages 12-25. First, Cure SMA launched a Quality of Life (QoL) survey to capture quantitative and qualitative information on this specific age demographic. Concurrently, Cure SMA invited SMA-affected individuals, ages 12-25, to create a three-minute video on their everyday experiences living with SMA. An inductive thematic analysis of the free-text survey questions along with the video contest findings are reported here.
RESULTS: Eighty-five individuals-6 type Is, 58 type IIs, and 21 type IIIs-completed the Quality of Life free-response, while six individuals participated in the SMA awareness video contest. In both settings, individuals detailed a variety of challenges, including but not limited to forming or maintaining close relationships, experiencing feelings of isolation, challenges with accessibility, independence, and dealing with the stigma of being perceived as mentally disabled. Individuals also discussed their successes, including but not limited to higher education enrollment and attendance, development of quality friendships, and perseverance through obstacles. Additionally, notably in the survey, 39% of respondents requested the creation of an SMA peer support group in efforts to connect with each other as well as collectively navigate the aforementioned challenges they face.
CONCLUSION: Together, these findings provide a rare glimpse into the unique mindsets, challenges and motivations of SMA adolescents and young adults, via patient-reported measures instead of caregiver proxy. The adolescent and young adult age demographics assessed represent a critical transition period in life and in SMA care. No one understands the needs of an adolescent or young adult with SMA better than the individuals themselves, and it is critical to encapsulate their insights to affect change.

Entities:  

Keywords:  Accessibility; Dependence; Disability; Emotional health; Fatigue; Peer-support group; Qualitative research; Quality of life in SMA adolescents and young adults; Spinal muscular atrophy

Mesh:

Year:  2021        PMID: 33618755      PMCID: PMC7898731          DOI: 10.1186/s13023-021-01701-y

Source DB:  PubMed          Journal:  Orphanet J Rare Dis        ISSN: 1750-1172            Impact factor:   4.123


  22 in total

1.  Spinal muscular atrophy: a timely review.

Authors:  Stephen J Kolb; John T Kissel
Journal:  Arch Neurol       Date:  2011-04-11

2.  Disease impact on general well-being and therapeutic expectations of European Type II and Type III spinal muscular atrophy patients.

Authors:  Françoise Rouault; Vanessa Christie-Brown; Ria Broekgaarden; Nicole Gusset; Doug Henderson; Patryk Marczuk; Inge Schwersenz; Gil Bellis; Christian Cottet
Journal:  Neuromuscul Disord       Date:  2017-02-03       Impact factor: 4.296

Review 3.  Spinal muscular atrophy: clinical classification and disease heterogeneity.

Authors:  Barry S Russman
Journal:  J Child Neurol       Date:  2007-08       Impact factor: 1.987

4.  Identification and characterization of a spinal muscular atrophy-determining gene.

Authors:  S Lefebvre; L Bürglen; S Reboullet; O Clermont; P Burlet; L Viollet; B Benichou; C Cruaud; P Millasseau; M Zeviani
Journal:  Cell       Date:  1995-01-13       Impact factor: 41.582

5.  Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications.

Authors:  K Zerres; S Rudnik-Schöneborn
Journal:  Arch Neurol       Date:  1995-05

6.  Indirect estimation of the prevalence of spinal muscular atrophy Type I, II, and III in the United States.

Authors:  Cathy Lally; Cynthia Jones; Wildon Farwell; Sandra P Reyna; Suzanne F Cook; W Dana Flanders
Journal:  Orphanet J Rare Dis       Date:  2017-11-28       Impact factor: 4.123

7.  A qualitative study of perceptions of meaningful change in spinal muscular atrophy.

Authors:  Sarah McGraw; Ying Qian; Jeff Henne; Jill Jarecki; Kenneth Hobby; Wei-Shi Yeh
Journal:  BMC Neurol       Date:  2017-04-04       Impact factor: 2.474

8.  Health, wellbeing and lived experiences of adults with SMA: a scoping systematic review.

Authors:  Hamish W Y Wan; Kate A Carey; Arlene D'Silva; Steve Vucic; Matthew C Kiernan; Nadine A Kasparian; Michelle A Farrar
Journal:  Orphanet J Rare Dis       Date:  2020-03-12       Impact factor: 4.123

9.  Understanding the experiences and needs of individuals with Spinal Muscular Atrophy and their parents: a qualitative study.

Authors:  Ying Qian; Sarah McGraw; Jeff Henne; Jill Jarecki; Kenneth Hobby; Wei-Shi Yeh
Journal:  BMC Neurol       Date:  2015-10-24       Impact factor: 2.474

10.  An overview of the Cure SMA membership database: Highlights of key demographic and clinical characteristics of SMA members.

Authors:  Lisa Belter; Suzanne F Cook; Thomas O Crawford; Jill Jarecki; Cynthia C Jones; John T Kissel; Mary Schroth; Kenneth Hobby
Journal:  J Neuromuscul Dis       Date:  2018
View more
  1 in total

1.  Improving Care and Empowering Adults Living with SMA: A Call to Action in the New Treatment Era.

Authors:  Maggie C Walter; Claudia Chiriboga; Tina Duong; Nathalie Goemans; Anna Mayhew; Laëtitia Ouillade; Maryam Oskoui; Ros Quinlivan; Juan F Vázquez-Costa; John Vissing; Laurent Servais
Journal:  J Neuromuscul Dis       Date:  2021
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.